A
Alexander Neumeister
Researcher at New York University
Publications - 199
Citations - 10292
Alexander Neumeister is an academic researcher from New York University. The author has contributed to research in topics: Serotonin transporter & Light therapy. The author has an hindex of 57, co-authored 199 publications receiving 9532 citations. Previous affiliations of Alexander Neumeister include National Institutes of Health & Yale University.
Papers
More filters
Journal ArticleDOI
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.
Carolina Johansson,Matthaeus Willeit,Christina Smedh,Jenny Ekholm,Tiina Paunio,Tuula Kieseppä,Dirk Lichtermann,Nicole Praschak-Rieder,Alexander Neumeister,Alexander Neumeister,Lars-Göran Nilsson,Siegfried Kasper,Leena Peltonen,Rolf Adolfsson,Martin Schalling,Timo Partonen +15 more
TL;DR: Diurnal preference was associated with both SAD and seasonality, supporting the hypothesis of a link between circadian rhythms and seasonal depression and involvement of circadian clock-related polymorphisms both in susceptibility to S AD and diurnal preference.
Journal ArticleDOI
Reduced Serotonin Type 1A Receptor Binding in Panic Disorder
Alexander Neumeister,Earle E. Bain,Allison C. Nugent,Richard E. Carson,Omer Bonne,David A. Luckenbaugh,William C. Eckelman,Peter Herscovitch,Dennis S. Charney,Wayne C. Drevets +9 more
TL;DR: In vivo evidence is provided for the first time for the involvement of 5-HT1ARs in the pathophysiology of PD, whereas both patient groups differed significantly from controls.
Journal ArticleDOI
Evidence for continuing neuropsychological impairments in depression
Petra Weiland-Fiedler,Kristine Erickson,Tracy Waldeck,David A. Luckenbaugh,Daniel Pike,Omer Bonne,Dennis S. Charney,Alexander Neumeister +7 more
TL;DR: In this article, the authors describe the neuropsychological functioning of fully remitted, unmedicated patients with a history of major depressive disorder by focusing on tasks related to prefrontal cortex functioning.
Journal ArticleDOI
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
Alexander Neumeister,Marc D. Normandin,Marc D. Normandin,Robert H. Pietrzak,Robert H. Pietrzak,Daniele Piomelli,Ming-Qiang Zheng,Ana Gujarro-Anton,Marc N. Potenza,Christopher R. Bailey,Shu-fei Lin,Soheila Najafzadeh,Jim Ropchan,Shannan Henry,Stefani Corsi-Travali,Richard E. Carson,Yiyun Huang +16 more
TL;DR: It is suggested that abnormal CB1 receptor-mediated anandamide signaling is implicated in the etiology of PTSD, and provide a promising neurobiological model to develop novel, evidence-based pharmacotherapies for this disorder.
Journal ArticleDOI
Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies.
James W. Murrough,Brian M. Iacoviello,Brian M. Iacoviello,Alexander Neumeister,Dennis S. Charney,Dan V. Iosifescu +5 more
TL;DR: It is proposed that deficient cognitive functioning, attention biases and the sustained negative affect characteristic of MDD can be understood as arising in part from dysfunctional prefrontal-subcortical circuitry and related disturbances in the cognitive control of emotion.